Alpha-lipoic acid is an effective inhibitor of human immuno-deficiency virus (HIV-1) replication

Summary

Alpha-lipoic acid, a naturally occuring disulfide-compound that acts as a cellular coenzyme, inhibits replication of HIV-1 in cultured lymphoid T-cells. Alpha-lipoic acid was added 16 hours after infection of the T-cell lines Jurkat, SupT1 and Molt-4 with HTLV IIIB and HIV-1 Wai (a wild type HIV-1 isolate). We observed a dose dependent inhibition of HIV-1-replication in CPE (Cytopathic effect) formation, reverse transcriptase activity and plaque formation on CD4-transformed HeLa-cells. An over 90% reduction of reverse transcriptase activity could be achieved with 70 μg alpha-lipoic acid/ml, a complete reduction of plaque-forming units at concentrations of ≥35 μg alpha-lipoic acid/ml. An augmentation of the antiviral activity was seen by combination of zidovudine and low dose of alpha-lipoic acid (7 μg/ ml). Trypan blue staining revealed no toxic effects of alpha-lipoic acids on peripheral blood mononuclear cells and T-cell lines even in concentrations of ≥70 μg/ml. Therefore, we propose the inclusion of alpha-lipoic acid into chemotherapy trials in combination with zidovudine.

This is a preview of subscription content, access via your institution.

Abbreviations

HIV:

Human immunodeficiency virus

HTLV:

Human T-lymphotropic virus

MOI:

multiplicity of infection

AZT:

Azidothymidine (zidovudine)

PBMC:

peripheral blood mononuclear cells

PHA:

Phythämagglutinin

CPE:

cytopathic effect

RT:

reverse transcriptase

CD:

Cluster of differentiation

cpm:

counts per minute

References

  1. 1.

    Chandra A, Demirhan I, Arya SK, Chandra P (1988) D-Penicillamin inhibits transactivation of human immunodeficiency virus type-1 (HIV-1) LTR by transactivator protein. FEBS Lett 236:282–286

    Google Scholar 

  2. 2.

    Chesebro B, Wehrly K (1988) Development of a sensitive quantitative focal assay for human immunodeficiency virus infectivity. J Virol 62:3779–3788

    Google Scholar 

  3. 3.

    Gregersen JP, Wege H, Preiss L, Jentsch KD (1988) Detection of human immunodeficiency virus and other retroviruses in cell culture supernatants by a reverse transcriptase microassay. J Virol Meth 19:161–168

    Google Scholar 

  4. 4.

    Harrison EH, McCormick DB (1974) Metabolism of d,1-lipoic-1,6-carbon-14-labeled acid in the rat. Arch Biochem Biophys 160:514–522

    Google Scholar 

  5. 5.

    Kubota SK, El-Farrash MA, Maki M, Harada S, Hatanaka M (1990) 2,3 Dimercapto-1-Propanol inhibits HIV-1 tat activity, viral production, and infectivity in vitro. AIDS Res Human Retroviruses 6:919–927

    Google Scholar 

  6. 6.

    Ohmori H, Yamauchi T, Zamamoto I (1986) Augmentation of the antibody response by lipoic acid in mice. I. Analysis of the mode of action in an in vitro cultures system. Jpn J Pharmacol 42:135–140

    Google Scholar 

  7. 7.

    Ohmori H, Yamauchi T, Zamamoto I (1986) Augmentation of the antibody response by lipoic acid in mice. II. Restoration of the antibody response in immunosuppressed mice. Jpn J Pharmacol 42:275–280

    Google Scholar 

  8. 8.

    Roederer M, Staal FJT, Raju PA, Ela SW, Herzenberg LA, Herzenberg LA (1990) Cytokine-stimulated human immunodeficiency virus replication is inhibited by N-acetyl-L-cysteine. Proc Natl Acad Sci USA 87:4884–4888

    Google Scholar 

  9. 9.

    Sachse G, Willms B (1980) Efficacy of thioctic acid in the therapy of peripheral diabetic neuropathy. Ref Internat Symp of the German association “Aspects of autonomic neuropathy in diabetes”. Hormone Metabol Res 9:105–108

    Google Scholar 

Download references

Author information

Affiliations

Authors

Additional information

We thank Susanne Gack, Maria Neundörfer and Ute Ehrmann for expert technical assistance.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Baur, A., Harrer, T., Peukert, M. et al. Alpha-lipoic acid is an effective inhibitor of human immuno-deficiency virus (HIV-1) replication. Klin Wochenschr 69, 722–724 (1991). https://doi.org/10.1007/BF01649442

Download citation

Key words

  • HIV inhibition
  • Alpha-lipoic acid-therapy